Skip to main content

Table 2 Summary characteristics for clinical and metabolic variables categorized by the status of MS

From: TriGlycerides and high-density lipoprotein cholesterol ratio compared with homeostasis model assessment insulin resistance indexes in screening for metabolic syndrome in the chinese obese children: a cross section study

 

Non-MS(n = 724)

MS(n = 252)

 

Median

P 25

P75

Median

P25

P75

Age, years

10.5

8.83

12

11.62

9.79

12.83

BMI, kg/m2

27.3

25.01

29.9

28.92

26.39

32.24

Systolic blood pressure, mmHg

114

105

122

126

112

135

Diastolic blood pressure, mmHg

67

61

72

70

65

78

Triglyceride, mg/dL

1.09

0.84

1.46

1.8

1.34

2.22

HDL cholesterol, mg/dL

1.24

1.1

1.43

0.96

0.85

1.06

TG/HDL-C

0.9

0.63

1.26

1.85

1.34

2.42

LDL cholesterol, mg/dL

2.34

2

2.74

2.55

2.21

3.03

Fasting plasma glucose, mg/dL

5.2

4.8

5.4

5.5

5

5.8

Fasting plasma insulin, mU/L

16.3

10.7

23.7

22

13.2

31.6

HOMA1-IR

3.67

2.39

5.48

5.42

3.23

7.58

HOMA2-IR

2.1

1.4

3.01

2.86

1.73

4.02

  1. MS Metabolic Syndrome, BMI body mass index, TG triglyceride, HDL-C HDL-cholesterol, LDL-C LDL-cholesterol, P25 percentile 25, P75 percentile 75, statistical significance were found in all the variables between the MS and Non-MS by Mann–Whitney test p < 0.05